(Q36560347)

14 August 2017

Prevalence and patterns of antidepressant drug use during pregnancy (English)

1 reference

14 August 2017

Toine Egberts

6

0 references

author name string

Tessa Ververs

1

1 reference

14 August 2017

Hans Kaasenbrood

2

1 reference

14 August 2017

Gerard Visser

3

1 reference

14 August 2017

Fred Schobben

4

1 reference

14 August 2017

Lolkje de Jong-van den Berg

5

1 reference

14 August 2017

8 August 2006

1 reference

European Journal of Clinical Pharmacology

14 August 2017

1 reference

14 August 2017

62

1 reference

14 August 2017

863-870

1 reference

14 August 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-006-0177-0

14 August 2017

0 references

cites work

Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-006-0177-0

Antidepressant drugs during pregnancy and infant congenital heart defect

21 January 2018

1 reference

12 December 2020

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

1 reference

12 December 2020

Paroxetine (Paxil) and congenital malformations

1 reference

12 December 2020

SSRIs in pregnancy and lactation: emphasis on neurodevelopmental outcome

1 reference

12 December 2020

The length of uncomplicated human gestation

1 reference

12 December 2020

Reintroduction of antidepressant therapy across pregnancy in women who previously discontinued treatment. A preliminary retrospective study

1 reference

12 December 2020

Prescribing during pregnancy and lactation with reference to the Swedish classification system. A population-based study among Danish women. The Euromap Group.

1 reference

12 December 2020

Medication use during pregnancy: data from the Avon Longitudinal Study of Parents and Children

1 reference

12 December 2020

Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study

1 reference

12 December 2020

NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of fluoxetine.

1 reference

12 December 2020

Fluoxetine use in early pregnancy

1 reference

12 December 2020

Prescription of drugs to pregnant women in France: the HIMAGE study

1 reference

12 December 2020

Paroxetine withdrawal in a neonate with historical and laboratory confirmation

1 reference

12 December 2020

Prescription drug use in pregnancy.

1 reference

12 December 2020

Antidepressant drug use in general practice: inter-practice variation and association with practice characteristics.

1 reference

12 December 2020

Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy

1 reference

12 December 2020

Identifying parents in pharmacy data: a tool for the continuous monitoring of drug exposure to unborn children

1 reference

12 December 2020

Drug use by pregnant women and comparable non-pregnant women in The Netherlands with reference to the Australian classification system

1 reference

12 December 2020

Do therapeutic indications of antidepressants change from one year to another?

1 reference

12 December 2020

Validation studies of drug exposures in pregnant women.

1 reference

12 December 2020

Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior

1 reference

12 December 2020

Treatment with Selective Serotonin Reuptake Inhibitors in the Third Trimester of Pregnancy : Effects on the Infant

1 reference

12 December 2020

Assessment and treatment of depression during pregnancy: an update

1 reference

12 December 2020

Drug prescription in pregnancy: analysis of a large statutory sickness fund population

1 reference

12 December 2020

10.1007/S00228-006-0177-0

Identifiers

DOI

1 reference

14 August 2017

1 reference